Weeks 9-12 advance to 8mg weekly
Ferroptosis in these cells disrupts immune homeostasis and contributes to inflammation and tissue injury ( Figure 5 )
That being said, we know, and the data bears this out, there are some patients who really prefer an oral agent and theyre not interested in taking an injectable formulation, said Pagidipati
Deficiency can also be caused by poor absorption
What the research shows: In the SURMOUNT clinical trials, patients taking tirzepatide lost an average of 2022% of their body weight over 72 weeks
Thus, the dynamics of GLP-1 needs to be carefully investigated in hyperthyroid mouse models in the future, which will help to understand the glucose metabolism in patients with clinical hyperthyroidism